Page last updated: 2024-11-07

phenoxazinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Phenoxazinones are heterocyclic compounds containing a phenoxazine ring system with a carbonyl group at the 10-position. They exhibit diverse biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. Their synthesis often involves condensation reactions of o-aminophenols with quinones or their precursors. The presence of the carbonyl group in phenoxazinones contributes to their reactivity and allows for further functionalization. The study of phenoxazinones has gained significant interest due to their potential applications in medicine and materials science. For instance, some phenoxazinone derivatives have shown promising activity against bacterial infections and cancer cell lines, motivating further research into their therapeutic potential.'

Cross-References

ID SourceID
PubMed CID114834
CHEMBL ID147062
SCHEMBL ID8067
MeSH IDM0074196

Synonyms (8)

Synonym
phenoxazinone
phenoxazin-3-one
CHEMBL147062
1916-63-8
3h-phenoxazin-3-one
SCHEMBL8067
UOMHBFAJZRZNQD-UHFFFAOYSA-N
DTXSID20172692

Research Excerpts

Overview

Phenoxazinone synthase is a copper-containing oxidase. It catalyzes the coupling of 2-aminophenols to form the 2-aminsophenoxaz inone chromophore.

ExcerptReferenceRelevance
"Phenoxazinone synthase is a copper-containing oxidase that catalyzes the coupling of 2-aminophenols to form the 2-aminophenoxazinone chromophore. "( Phenoxazinone synthase: mechanism for the formation of the phenoxazinone chromophore of actinomycin.
Barry, CE; Begley, TP; Nayar, PG, 1989
)
3.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID86213Compound concentration required to reduce the cell proliferation of larynx carcinoma cells by 50%, using MTT method.2002Journal of medicinal chemistry, Nov-21, Volume: 45, Issue:24
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
AID86979Compound concentration required to reduce the cell proliferation of cervix carcinoma Hela cells by 50%, using MTT method.2002Journal of medicinal chemistry, Nov-21, Volume: 45, Issue:24
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
AID44014Compound concentration required to reduce the cell proliferation of human acute T-lymphoblastic leukemia CCRF-CEM cells by 50%, using MTT method.2002Journal of medicinal chemistry, Nov-21, Volume: 45, Issue:24
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
AID44374Compound concentration required to reduce the cell proliferation of human acute B-lymphoblastic leukemia CCRF-SB cells by 50%, using MTT method.2002Journal of medicinal chemistry, Nov-21, Volume: 45, Issue:24
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
AID104442Compound concentration required to reduce the cell proliferation of human CD4+T cells by 50%, using MTT method.2002Journal of medicinal chemistry, Nov-21, Volume: 45, Issue:24
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (38.18)18.7374
1990's5 (9.09)18.2507
2000's9 (16.36)29.6817
2010's15 (27.27)24.3611
2020's5 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.22 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.67 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (96.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]